1. Home
  2. CWAN vs BCPC Comparison

CWAN vs BCPC Comparison

Compare CWAN & BCPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CWAN
  • BCPC
  • Stock Information
  • Founded
  • CWAN 2004
  • BCPC 1967
  • Country
  • CWAN United States
  • BCPC United States
  • Employees
  • CWAN N/A
  • BCPC N/A
  • Industry
  • CWAN Computer Software: Prepackaged Software
  • BCPC Major Chemicals
  • Sector
  • CWAN Technology
  • BCPC Industrials
  • Exchange
  • CWAN Nasdaq
  • BCPC Nasdaq
  • Market Cap
  • CWAN 5.8B
  • BCPC 5.2B
  • IPO Year
  • CWAN 2021
  • BCPC N/A
  • Fundamental
  • Price
  • CWAN $20.84
  • BCPC $152.09
  • Analyst Decision
  • CWAN Buy
  • BCPC Strong Buy
  • Analyst Count
  • CWAN 10
  • BCPC 1
  • Target Price
  • CWAN $31.50
  • BCPC $180.00
  • AVG Volume (30 Days)
  • CWAN 3.5M
  • BCPC 162.1K
  • Earning Date
  • CWAN 08-06-2025
  • BCPC 07-31-2025
  • Dividend Yield
  • CWAN N/A
  • BCPC 0.57%
  • EPS Growth
  • CWAN N/A
  • BCPC 17.80
  • EPS
  • CWAN 1.71
  • BCPC 4.17
  • Revenue
  • CWAN $475,948,000.00
  • BCPC $964,544,000.00
  • Revenue This Year
  • CWAN $63.46
  • BCPC $8.74
  • Revenue Next Year
  • CWAN $29.41
  • BCPC $6.85
  • P/E Ratio
  • CWAN $12.12
  • BCPC $36.54
  • Revenue Growth
  • CWAN 23.21
  • BCPC 3.76
  • 52 Week Low
  • CWAN $19.46
  • BCPC $145.70
  • 52 Week High
  • CWAN $35.71
  • BCPC $185.96
  • Technical
  • Relative Strength Index (RSI)
  • CWAN 36.76
  • BCPC 38.44
  • Support Level
  • CWAN $21.00
  • BCPC $146.41
  • Resistance Level
  • CWAN $21.66
  • BCPC $153.86
  • Average True Range (ATR)
  • CWAN 0.63
  • BCPC 3.19
  • MACD
  • CWAN -0.04
  • BCPC -0.34
  • Stochastic Oscillator
  • CWAN 7.76
  • BCPC 38.80

About CWAN Clearwater Analytics Holdings Inc.

Clearwater Analytics describes its mission as aiming to be the world's most trusted and comprehensive technology platform for the entire investment cycle. Clearwater has historically focused on back-office functions such as investment accounting, but with acquisitions such Enfusion, Beacon, and Bistro, the firm has broadened its focus with front-office and middle-office capabilities. Clearwater primarily serves insurance companies, asset managers, hedge funds, and corporate treasuries. Pro forma for Enfusion, about 76% of Clearwater's revenue is generated in the US.

About BCPC Balchem Corporation

Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.

Share on Social Networks: